+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rett Syndrome"

Rare Neurological Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Rare Neurological Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Rett Syndrome Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rett Syndrome Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
From
Developmental Neuropathology. 2nd Edition - Product Thumbnail Image

Developmental Neuropathology. 2nd Edition

  • Book
  • April 2018
  • 560 Pages
  • 13 Results (Page 1 of 1)
Loading Indicator

Rett Syndrome is a rare neurological disorder that affects the development of the brain in children, primarily girls. It is characterized by a period of normal development followed by a regression of language, motor, and social skills. Symptoms include repetitive hand movements, breathing irregularities, and seizures. Treatment focuses on managing symptoms and improving quality of life. The Rett Syndrome market is a subset of the larger Neurology market. It is a small but growing market, with a focus on developing treatments and therapies to improve the lives of those affected. Research and development efforts are ongoing, with a focus on developing new treatments and therapies. Companies in the Rett Syndrome market include Biomarin Pharmaceuticals, Inc., PTC Therapeutics, Inc., and Rettsyndrome.org. Show Less Read more